# Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors

> **NCT00253344** · PHASE1 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 33 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** docetaxel
- **DRUG:** lenalidomide

## Key facts

- **NCT ID:** NCT00253344
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00253344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00253344, "Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00253344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*